Handelsbanken Fonder Ab Emergent Bio Solutions Inc. Transaction History

Handelsbanken Fonder Ab

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 03, 2021	BUY	$56.61 - $80.46 $73,593 - $104,597	1,300 Added 16.86%	9,009 $567,000
Q2 2020 Aug 13, 2020	BUY	$54.33 - $89.52 $418,829 - $690,109	7,709 New	7,709 $610,000

173

36.8M

336K

203K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $291M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.